1-6 of 6
Kia Heimersson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cellular and Molecular Effects of Suspending Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia in Sustained Partial Remission

Marzia Palma, Maria Lisa Andersson, Tom Adriaan Mulder, Kia Heimersson, Anna Berglöf, Lucia Peña Perez, Teresa Del Peso Santos, Yesid Alvarado Valero, Rula Zain-Luqman, Robert Månsson, Richard Rosenquist, Edvard C.I. Smith, Anders Österborg, Jeanette Lundin
Journal: Blood
Blood (2024) 144 (Supplement 1): 6756.
https://doi.org/10.1182/blood-2024-198001
Published: 2024
Journal Articles

Expression of the Fractalkine Receptor (CX3CR1) Is Significantly Increased in Immune Cells of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma patients with Active Disease

Marzia Palma, MD PhD, Tom A. Mulder, MD, Kia Heimersson, Li-Sophie Rathje, PhD, Thomas Olin, MSc,PhD, Johan Schultz, MSc,PhD, Håkan Mellstedt, MD PhD, Anders Österborg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5445.
https://doi.org/10.1182/blood-2019-121818
Published: 2019
Journal Articles

Reduction of Tumor Burden Rather Than Off-Target Effects Drives Changes in T-Cell Number and Profile during Prolonged Ibrutinib Treatment in Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

Marzia Palma, MD PhD, Kia Heimersson, Tom A. Mulder, MD, Barbro Näsman-Glaser, Anders Österborg, MD PhD Prof., Håkan Mellstedt, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4421.
https://doi.org/10.1182/blood-2018-99-110236
Published: 2018
Journal Articles

Long-Term Treatment with Ibrutinib in Chronic Lymphocytic Leukemia Patients Normalizes CD3 + and CD8 + T Cells and Immune Checkpoints Expression but Gradually Leads to CD4 + T-Cell Depletion

Marzia Palma, MD PhD, Kia Heimersson, Barbro Näsman-Glaser, Håkan Mellstedt, MD PhD, Anders Österborg, MD PhD Prof.
Journal: Blood
Blood (2017) 130 (Supplement 1): 4322.
https://doi.org/10.1182/blood.V130.Suppl_1.4322.4322
Published: 2017
Journal Articles

T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Display Dysregulated Expression of Immune Checkpoint Molecules and Activation Markers Mainly Restricted to CD4 + Cells and Correlated with Disease Activity

Marzia Palma, MDPhD, Giusy Gentilcore, MSc, Fariba Mozaffari, PhD, Kia Heimersson, Barbro Näsman-Glaser, Lotta Hansson, MD PhD, Anders Österborg, MDPhD, Håkan Mellstedt, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4132.
https://doi.org/10.1182/blood.V126.23.4132.4132
Published: 2015
Journal Articles

Vaccination with Dendritic Cells Loaded with Autologous Leukemic Cells in Combination with Low-Dose Lenalidomide Induced Immune Responses in Chronic Lymphocytic Leukemia (CLL) Patients

Lotta Hansson, MD PhD, Marzia Palma, MD PhD, Lars Adamson, Harriet Ryblom, Barbro Näsman-Glaser, Ingrid Eriksson, Kia Heimersson, Giusy Gentilcore, Håkan Mellstedt, MD PhD, Anders Österborg
Journal: Blood
Blood (2014) 124 (21): 4685.
https://doi.org/10.1182/blood.V124.21.4685.4685
Published: 2014